Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Aldesleukin by Iltoo Pharma for Miscarriage: Likelihood of Approval
Aldesleukin is under clinical development by Iltoo Pharma and currently in Phase II for Miscarriage. According to GlobalData, Phase II...
Aldesleukin by Iltoo Pharma for Bipolar Disorder (Manic Depression): Likelihood of Approval
Aldesleukin is under clinical development by Iltoo Pharma and currently in Phase II for Bipolar Disorder (Manic Depression). According to...
Aldesleukin by Iltoo Pharma for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Aldesleukin is under clinical development by Iltoo Pharma and currently in Phase III for Amyotrophic Lateral Sclerosis. According to GlobalData,...
Aldesleukin by Iltoo Pharma for Allergic Rhino-Conjunctivitis: Likelihood of Approval
Aldesleukin is under clinical development by Iltoo Pharma and currently in Phase II for Allergic Rhino-Conjunctivitis. According to GlobalData, Phase...
Aldesleukin by Iltoo Pharma for Bipolar Disorder (Manic Depression): Likelihood of Approval
Aldesleukin is under clinical development by Iltoo Pharma and currently in Phase II for Bipolar Disorder (Manic Depression). According to...
Aldesleukin by Iovance Biotherapeutics for Graft Versus Host Disease (GVHD): Likelihood of Approval
Aldesleukin is under clinical development by Iovance Biotherapeutics and currently in Phase II for Graft Versus Host Disease (GVHD). According...